「基礎醫學-病理學」腫瘤學oncology

三陰性(triple negative)乳癌

三陰性(triple negative)乳癌的定義,包含雌激素受體(estrogen receptor)陰性、孕激素受體(progesterone receptor)陰性和第二型人類表皮生長因子接受體(human epidermal growth factor receptor 2)陰性。
Triple-negative breast cancer (TNBC) is a type of breast cancer that is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression.

通常這些受體和乳癌細胞的生長和分化有著關聯的關係:
These receptors are typically associated with the growth and differentiation of breast cancer cells:
雌激素受體 (ER) 和 孕激素受體 (PR) 是激素受體,可結合雌激素和孕激素,促進乳癌細胞的生長。
ER and PR are hormone receptors that can bind to estrogen and progesterone, respectively, and promote the growth of breast cancer cells.
人類表皮生長因子受體 2 (HER2) 是一種酪氨酸激酶受體,可促進乳癌細胞的生長和分化。
HER2 is a tyrosine kinase receptor that can promote the growth and differentiation of breast cancer cells.

三陰性乳癌佔所有乳癌的 15%-20%,通常更具侵襲性,預後更差。
TNBC accounts for 15-20% of all breast cancers and is typically more aggressive and has a worse prognosis.

然而細胞角蛋白 (cytokeratin) 是一種中間絲蛋白,在細胞骨架中起著重要作用。
However, cytokeratin is an intermediate filament protein that plays an important role in the cell cytoskeleton.

留言

最新文章